Creative Medical Technology (CELZ)

• Market cap: $7.13M
• 1 day: -13.45%
• 5 days: -12.27%
• 1 month: -19.25%
• 3 months: 3.76%
• 6 months: -8.96%
• Year to date: -2.03%
• 1 year: -21.22%
• 5 years: -91.27%
• 10 years: -91.27%
• Sector: Healthcare
• Industry: Biotechnology

About: Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.

Employees: 4